期刊文献+

中西药对照治疗病态窦房结综合征临床疗效观察 被引量:9

Comparative Observation on Clinical Therapeutic Efficacy of Chinese Herbal Medicine and Western Medicine on Sick Sinus Syndrome
在线阅读 下载PDF
导出
摘要 目的观察中西药治疗病态窦房结综合征的临床疗效。方法将171例确诊为病态窦房结综合征患者随机分为治疗组和对照组,治疗组(90例)予强心复脉合剂口服,对照组(81例)予阿托品口服,疗程4周。治疗结束后比较2组的临床症状、24 h动态心电图和左心室射血分数(LVEF)的变化。结果临床疗效:治疗组和对照组比较,差异有显著性意义(P<0.01);24 h动态心电图:治疗组和对照组心率提高总有效率分别为92%和36%,24 h平均心率分别增加10次/min和4次/min,2组差异有显著性意义(P<0.01);LVEF:治疗组与对照组治疗后比较,有明显改善心功能的作用(P<0.01)。结论强心复脉合剂可以明显改善患者的临床症状、提高心率和改善心功能,是治疗病态窦房结综合征的有效药物。 Objective To observe the difference clinical therapeutic efficacy of the Chinese herbal medicine and western medicine on sick sinus syndrome patients. Method 171 patients with sick sinus syndrome were randomly divided into treatment group and control group. 90 patients in the treatment group were given Qiangxin Fumai Mixture while the other 81 patients in the control group were given atropine. The therapeutic course was four weeks in each group. The changes of clinical manifestations, electrocardiogram (24 h Holter monitoring ECG) and left ventricular ejection fraction (LVEF) were compared between two groups. Result Clinical therapeutic efficacy: There was significant difference between two groups (P〈0.01). 24 h Holter monitoring ECG: The total effective rate of the treatment group was 92% and that of the control group was 36%, with the average increases of heart rates in 24 hours were 10/min and 4/min, respectively. There was significant difference between two groups (P〈0.01). LVEF: The LVEF in the treatment group was improved evidently compared with that in the control group after treatment (P〈0.01). Qiangxin Fumal Mixture is effective in treating sick sinus syndrome by improving clinical symptoms, heart rates and heart function.
出处 《中国中医药信息杂志》 CAS CSCD 2008年第4期15-17,共3页 Chinese Journal of Information on Traditional Chinese Medicine
基金 国家中医药管理局资助项目(02-03LP53)
关键词 病态窦房结综合征 强心复脉合剂 临床疗效 sick sinus syndrome Qiangxin fumal Mixture clinical therapeutic efficacy
  • 相关文献

参考文献9

二级参考文献38

  • 1金艳,曹克将.骨髓干细胞心肌移植进展及其致心律失常可能[J].中国心脏起搏与心电生理杂志,2004,18(6):480-482. 被引量:8
  • 2任晓庆,浦介麟,张澍,贾玉和,吴国玫,孟亮,王方正.自体骨髓间叶干细胞诱导分化移植治疗房室阻滞的初步观察[J].中国心脏起搏与心电生理杂志,2005,19(1):48-52. 被引量:17
  • 3胡德胜,郭伟星,于杰.心血管疾病活血化瘀论治[J].中西医结合心脑血管病杂志,2006,4(1):66-67. 被引量:25
  • 4陈明哲.心脏病学[M].北京:北京医科大学出版社,2001.1196.
  • 5[1]Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284: 143-147.
  • 6[2]Minguell JJ, Ericess A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood), 2001, 226: 507-520.
  • 7[3]Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 1997, 276: 71-74.
  • 8[4]Minguell JJ, Conget P, Erices A. Biology and clinical utilization of mesenchymal progenitor cells. Braz J Med Biol Res, 2000, 33: 881-887.
  • 9[5]Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Med, 1998, 4: 929-933.
  • 10[6]Reinecke H, Murry CE. Transmural replacement of myocardium after skeletal myoblast grafting into the heart: too much of a good thing.Cardiovac Pathol, 2000, 9: 337-344.

共引文献378

同被引文献102

引证文献9

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部